Beurs gesloten -
Nasdaq
22:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
883,2
USD
|
-0,84%
|
|
-1,52%
|
+0,56%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
41.049
|
50.990
|
66.029
|
77.057
|
93.403
|
95.284
|
-
|
-
|
Bedrijfswaarde
1 |
35.291
|
50.098
|
56.196
|
77.057
|
84.542
|
86.606
|
81.922
|
77.197
|
K/w-verhouding
|
20,3
x
|
15,8
x
|
8,77
x
|
18,9
x
|
25,3
x
|
23,9
x
|
22,6
x
|
18,9
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
5,22
x
|
6
x
|
4,11
x
|
6,33
x
|
7,12
x
|
6,85
x
|
6,41
x
|
5,94
x
|
Bedrijfswaarde/omzet
|
4,49
x
|
5,9
x
|
3,5
x
|
6,33
x
|
6,45
x
|
6,23
x
|
5,51
x
|
4,81
x
|
Bedrijfswaarde/EBITDA
|
10,3
x
|
11,8
x
|
5,71
x
|
12,7
x
|
15,2
x
|
15,6
x
|
13,6
x
|
11,4
x
|
Bedrijfswaarde/FCF
|
17,6
x
|
25
x
|
8,61
x
|
17,4
x
|
21,8
x
|
18,2
x
|
17,4
x
|
14,4
x
|
FCF Yield
|
5,67%
|
4%
|
11,6%
|
5,74%
|
4,58%
|
5,49%
|
5,76%
|
6,97%
|
Price to Book
|
3,7
x
|
4,71
x
|
3,56
x
|
3,41
x
|
3,64
x
|
3,28
x
|
2,8
x
|
2,4
x
|
Aantal aandelen (in duizenden)
|
109.323
|
105.544
|
104.556
|
106.802
|
106.347
|
107.886
|
-
|
-
|
Referentieprijs
2 |
375,5
|
483,1
|
631,5
|
721,5
|
878,3
|
883,2
|
883,2
|
883,2
|
Datum van publicatie
|
6/02/20
|
5/02/21
|
4/02/22
|
3/02/23
|
2/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
7.863
|
8.497
|
16.072
|
12.173
|
13.117
|
13.907
|
14.861
|
16.038
|
EBITDA
1 |
3.420
|
4.244
|
9.835
|
6.060
|
5.547
|
5.538
|
6.033
|
6.754
|
Bedrijfsresultaat (EBIT)
1 |
2.210
|
3.577
|
8.947
|
5.719
|
5.126
|
5.230
|
5.571
|
6.224
|
Operationele Marge
|
28,1%
|
42,09%
|
55,67%
|
46,98%
|
39,08%
|
37,6%
|
37,49%
|
38,81%
|
Resultaat voor belastingen (EBT)
1 |
2.429
|
3.810
|
9.326
|
4.859
|
4.199
|
4.720
|
4.977
|
5.652
|
Nettowinst (verlies)
1 |
2.116
|
3.513
|
8.075
|
4.338
|
3.954
|
4.320
|
4.531
|
5.371
|
Nettomarge
|
26,91%
|
41,35%
|
50,25%
|
35,64%
|
30,14%
|
31,06%
|
30,49%
|
33,49%
|
WPA
2 |
18,46
|
30,52
|
71,97
|
38,22
|
34,77
|
36,89
|
39,01
|
46,70
|
Free Cash Flow
1 |
2.000
|
2.004
|
6.529
|
4.425
|
3.875
|
4.752
|
4.716
|
5.379
|
FCF-marge
|
25,44%
|
23,58%
|
40,63%
|
36,35%
|
29,54%
|
34,17%
|
31,74%
|
33,54%
|
Kasstroomconversie (ebitda)
|
58,5%
|
47,2%
|
66,39%
|
73,01%
|
69,86%
|
85,8%
|
78,17%
|
79,64%
|
Kasstroomconversie (nettowinst)
|
94,55%
|
57,03%
|
80,86%
|
101,99%
|
98,02%
|
110%
|
104,1%
|
100,15%
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
6/02/20
|
5/02/21
|
4/02/22
|
3/02/23
|
2/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
3.453
|
4.952
|
2.965
|
2.857
|
2.936
|
3.414
|
3.162
|
3.158
|
3.363
|
3.434
|
3.222
|
3.408
|
3.576
|
3.732
|
3.582
|
EBITDA
1 |
2.057
|
2.903
|
1.558
|
1.344
|
1.488
|
1.637
|
1.315
|
1.351
|
1.488
|
1.395
|
1.195
|
1.320
|
1.440
|
1.606
|
1.290
|
Bedrijfsresultaat (EBIT)
1 |
1.847
|
2.640
|
1.483
|
1.285
|
1.413
|
1.537
|
1.215
|
1.248
|
1.382
|
1.282
|
1.170
|
1.262
|
1.376
|
1.444
|
1.400
|
Operationele Marge
|
53,5%
|
53,31%
|
50,03%
|
44,99%
|
48,12%
|
45,02%
|
38,43%
|
39,51%
|
41,11%
|
37,33%
|
36,3%
|
37,04%
|
38,49%
|
38,68%
|
39,09%
|
Resultaat voor belastingen (EBT)
1 |
1.817
|
2.503
|
1.061
|
963,2
|
1.510
|
1.325
|
858
|
1.083
|
1.111
|
1.148
|
1.212
|
1.304
|
1.432
|
1.287
|
-
|
Nettowinst (verlies)
1 |
1.632
|
2.229
|
973,5
|
852,1
|
1.316
|
1.197
|
817,8
|
968,4
|
1.008
|
1.160
|
888,3
|
1.032
|
1.179
|
1.264
|
1.283
|
Nettomarge
|
47,27%
|
45,01%
|
32,83%
|
29,82%
|
44,81%
|
35,06%
|
25,86%
|
30,66%
|
29,97%
|
33,77%
|
27,57%
|
30,28%
|
32,98%
|
33,87%
|
35,82%
|
WPA
2 |
14,33
|
19,69
|
8,610
|
7,470
|
11,66
|
10,50
|
7,170
|
8,500
|
8,890
|
10,19
|
7,910
|
9,194
|
10,01
|
10,21
|
11,49
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
4/11/21
|
4/02/22
|
4/05/22
|
3/08/22
|
3/11/22
|
3/02/23
|
4/05/23
|
3/08/23
|
2/11/23
|
2/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
5.757
|
891
|
9.833
|
-
|
8.862
|
8.679
|
13.362
|
18.087
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
2.000
|
2.004
|
6.529
|
4.425
|
3.875
|
4.752
|
4.716
|
5.379
|
ROE (netto-inkomsten/eigen vermogen)
|
28,5%
|
33,2%
|
54,2%
|
24,9%
|
20,7%
|
18,7%
|
17,3%
|
16,7%
|
ROA (netto-inkomsten/totale activa)
|
15,9%
|
22%
|
37,9%
|
18,9%
|
16,2%
|
12%
|
11,9%
|
12,5%
|
Totale activa
1 |
13.270
|
15.984
|
21.299
|
22.956
|
24.412
|
35.907
|
38.226
|
42.921
|
Nettoactief per aandeel
2 |
102,0
|
102,0
|
178,0
|
212,0
|
241,0
|
269,0
|
315,0
|
369,0
|
Cashflow per aandeel
2 |
21,20
|
22,70
|
63,10
|
44,20
|
40,40
|
48,80
|
48,60
|
57,80
|
Capex
1 |
430
|
615
|
552
|
590
|
719
|
853
|
799
|
765
|
Capex/omzet
|
5,46%
|
7,23%
|
3,43%
|
4,85%
|
5,48%
|
6,13%
|
5,38%
|
4,77%
|
Datum van publicatie
|
6/02/20
|
5/02/21
|
4/02/22
|
3/02/23
|
2/02/24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
883,2
USD Gemiddelde koersdoel
1.038
USD Spread / Gemiddelde doel +17,54% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +0,56% | 95,28 mld. | | -2,31% | 103 mld. | | +1,69% | 22,15 mld. | | -17,37% | 21,02 mld. | | -9,30% | 18,15 mld. | | -41,01% | 16,74 mld. | | -14,85% | 16,05 mld. | | +3,21% | 13,68 mld. | | +33,54% | 12,17 mld. | | -24,71% | 8,24 mld. |
Biotherapeutische geneesmiddelen
|